Regulation of cell surface expression of BLT1.
INTRODUCTION

Radioligand
Radioactivity contained in the cell pellet was counted in liquid scintillation using a b counter.
Inositol phosphate determination -COS-7 cells were plated in 30 mm dishes (2,0 x 10 5 cells/dish) and cultured 24 h before transient transfection with cDNAs encoding WT or mutant BLT1 in combination with cDNA of Ga 1 6 subunit. In brief, 24 h post-transfection, cells were labeled and the following day, stimulated with 100 nM LTB 4 . Inositol phosphates (IP) were then extracted and radioactivity was counted as described previously (34). Total IP levels represent IP production in response to the agonist, over basal levels (or unstimulated). Constitutive activity was determined by comparing the ratio between the basal IP levels of mutant and WT receptors.
Flow cytometry studies -COS-7 cells transiently expressing the Myc-tagged WT or mutant BLT1 were subjected to flow cytometry analysis. Cells (2,5 x 10 5 ) were labeled as previously described (34) with anti-Myc followed by incubation with fluorescein isothiocyanateconjugated goat anti-mouse IgG antibody. All measures were performed on a FACScan flow cytometer using CellQuest sofware (Becton-Dickinson). Molecular modeling -The modeling and rendering of BLT1 were executed using the INSIGHTII suite of programs (Accel Ins., San Diego, CA). All the calculations were performed on an SGI Octane2 workstation (Silicon Graphics Ins., Mountain View, CA.), as described previously (36). Briefly, a pairwise sequence alignment between the primary structures of BLT1 (SwissProt Accession number GenBank accession no. D89078) and the Bovine Rhodopsin (PDB: 1L9H) was performed using the program HOMOLOGY. The sequences of the two proteins were aligned so as to equivalence the positions of the following conserved residues: Asn 5 5 -Asn1.50 3 6 (the superscripts represent the residue numbering in rhodopsin structure PDB code 1F88, and human BLT1 sequence, respectively, and 1.50 is the numbering in the standardized nomenclature), Asp 8 3 -Asp2.50 6 4 , Arg to the sequence of the BLT1. To relieve residual strain resulting from suboptimal positioning of the side chains, the resulting model was subjected to energy minimization using the program DISCOVER with consistent valence forcefield (37). During this process, the C a atoms and the side chains of conserved residues were kept fixed at their positions in the rhodopsin crystal structure. A distance-dependent dielectric constant of 4 was used with simple harmonic potential for bond length energy. No cross-term energies were included and the peptide bonds were forced to planarity.
Internalization assay
Statistical analysis -Data were analyzed for statistical significance using Student's paired t test. Differences were considered significant at p<0.05.
RESULTS
WT and mutant BLT1 were expressed in a mammalian expression system in order to determine and characterize structural elements involved in BLT1 trafficking and receptor activation.
Motifs located in the carboxyl-terminal tail of the receptor were investigated with regard to receptor expression, targeting to the membrane and functionality.
Structural determinants of BLT1 C-tail are essential for regulation of BLT1 expression.
We previously reported that a complete C-tail-truncated BLT1 (G291stop) showed increased numbers of [ 3 H]-LTB 4 binding sites and a greater inositol phosphates (IP) production in response to LTB 4 stimulation than WT BLT1 (33). In order to define whether selective BLT1
determinants could regulate its cell surface trafficking, we created two chimeric receptors composed of the main core of BLT1: residues 1 to 291 at the end of TM7 of BLT1 and the C-tail of either the platelet-activated factor receptor (PAFR) or the LTD 4 receptor CysLT1 (Fig. 1B) . The amino acids present in the C-tail of each receptor are shown in Figure 1A . Chimeric receptors (BLT1-PAFR and BLT1-CysLT1) were transiently expressed in COS-7 cells and were present at the plasma membrane as assessed by [ 3 H]-LTB 4 binding (Table I) . Nonlinear regression analysis of competition binding curves revealed the presence of one class of binding sites exhibiting high affinity for LTB 4 (BLT1-PAFR, K d = 3.6 ± 0.7 nM; BLT1-CysLT1, K d = 6.7 ± 1.9 nM). These K d values were slightly higher than the value for WT BLT1 value (K d = 1.0 ± 0.5 nM) ( Table I) .
We next investigated whether those chimeric receptors were able to transduce LTB 4 signaling. Total IP accumulation was monitored in COS-7 cells coexpressing Ga 16 subunit protein and either chimeric or WT receptor. Surprisingly, in response to 100 nM of LTB 4 , IP production was markedly increased for both BLT1-PAFR (155 ± 16 %) and BLT1-CysLT1 (163 ± 18 %) in comparison with WT (defined as 100 %) ( Fig. 2A) . Furthermore, the increased ability of the chimeric BLT1 to transduce LTB 4 signaling was associated with a higher number of binding sites, as shown by [ 3 H]-LTB 4 saturation binding curves (Fig. 2B) . These results suggest that the C-tail of WT BLT1 contains a signal that is not conserved in PAFR or CysLT1 C-tail, which controls BLT1 trafficking or functional expression at the cell surface.
We further sought to define the structural determinants present in the C-tail that could regulate BLT1 expression. Since a partially C-tail-truncated BLT1 mutant (G319stop) had shown binding characteristics similar to WT BLT1 (33), we investigated the cytoplasmic segment comprising residues 291 to 319. Two types of structural determinants located within the 291-319 C-tail segment could be involved in receptor trafficking: phospho-acceptor sites (S/T) and dileucine motifs (LL). Notably, the addition of PAFR and CysLT1 C-tails containing potential phospho- Consequently, BLT1 C-tail dileucine motifs were further studied.
Characterization of dileucine mutant BLT1.
Dihydrophobic motifs, such as leucine-valine and leucine-leucine are involved in efficient trafficking of several transmembrane proteins through sorting, localization or internalization signals as observed for the b 2 -AR and CXCR4 (13, 20, 21) . Two dileucine motifs are located between residues 291-319 of the BLT1 C-tail. In order to assess whether the dileucines were essential for the WT phenotype, we used site-directed mutagenesis to disrupt L292, L293 and L304, L305 in the full-length BLT1. Leucines were substituted to alanines so as to change each motif alone or in combination, generating three new mutant receptors: 2L(292-3)/A, 2L(304-5)/A and 4L/A mutant BLT1 (Fig. 1B) . Again, mutant receptors displayed a higher K d for LTB 4 (respective K d values:
4.47 ± 1.47 nM, 12.2 ± 3.0 nM, 10.6 ± 2.4 nM) than the WT BLT1 (Table I) . LTB 4 -induced IP accumulation was increased for the 4L/A mutant receptor (136 ± 17 %) when compared to the WT (defined as 100%) (Fig. 3A) . Interestingly, mutation of the distal dileucine motif 2L(304-5)/A led to a significant increase in IP production upon LTB 4 exposure (177 ± 22 %), whereas mutation of the proximal motif 2L(292-3)/A had no detectable effect (108 ± 22 %). Similar results were also observed in a time course study of IP production ( Fig. 3B ).
We next addressed whether dileucines might regulate BLT1 expression. Saturation binding curves correlated with the IP production, given that the 4L/A and the 2L(304-5)/A mutant receptors showed higher numbers of binding sites at the plasma membrane, but saturation could not be achieved (Fig. 3C ). In contrast, WT and the 2L(292-3)/A BLT1 binding sites for LTB 4 could be saturated. Overall, these results suggest that leucines 304 and 305 are responsible for the phenotype observed with the G291stop deletion.
We assessed the expression levels of Myc-tagged WT and mutant BLT1 at the plasma membrane by flow cytometry analysis. Surprisingly, the mean fluorescence intensity of COS-7 cells expressing each mutant receptor did not significantly vary from that of WT BLT1 (Fig.4 , Table II ). Similar results were observed when the number of Myc + cells was evaluated (Table II) .
Thus, the cell surface expression of the protein was not affected by removal of either one or both of the dileucine motifs and hence, the increased binding capacity of the population of receptors was not the consequence of a higher number of cell surface BLT1. Therefore, it could be hypothesized that the distal dileucine motif regulated in some way LTB 4 binding or LTB 4 Table   III ).
Molecular modeling reveals key hydrophobic interactions.
We used molecular modeling to gain insight into the structure-function of the two dileucine motifs located within the C-tail of BLT1. We show in Figure 7A and B, a homology model of the BLT1. The bovine rhodopsin structure was used as template and homology modeling was performed as described in "Experimental Procedures". As seen with the bovine rhodopsin structure, BLT1 shows a short amphipatic a-helix (helix VIII), which lies perpendicular to helix VII. It shows the two dileucine motifs located on the same face of this eighth helix, with the proximal L292-L293 motif at the beginning of the helix (in white) and the distal L304-L305 motif at the end of the helix (in yellow). It must be noted that this model represents the inactive form of the BLT1, since in the crystal structure of rhodopsin the receptor was in its inactive state. Analysis of the model indicates that L304-L305 are involved in a hydrophobic core with other hydrophobic residues in helix VIII (the highly conserved F300 and V301, in blue) and in helix I (F38, W41, L44, in green). This hydrophobic core could be involved in stabilizing the inactive state of the receptor.
DISCUSSION
Little is known about structural determinants regulating expression and trafficking of BLT1, the high affinity receptor for LTB 4 . In this study, we show that a dileucine-based motif (L304-L305) located in the C-tail of BLT1 regulates both receptor internalization and the numbers of cell surface binding sites for LTB 4 .
Cytoplasmic domains of GPCRs contain specific motifs involved in signal transduction and regulation, trafficking and receptor turnover. As a member of this superfamily of receptors, BLT1 285 , located respectively in the third intracellular loop and TM7, many phosphoacceptor residues (Ser/Thr) mostly located within the C-tail of the receptor and two C-tail dileucine-based sorting motifs (Fig. 1A) .
Structural determinants responsible for BLT1 trafficking
A C-tail-truncated BLT1 (G291stop) demonstrated an increased number of binding sites for 
BLT1 internalization
It has been proposed that sorting of proteins during endocytosis and biosynthesis is achieved via similar mechanisms (39) . Clathrin-coated pit formation recruits a clathrin lattice and the AP-2 complex to the plasma membrane, whereas AP-1 is lured to the trans-Golgi network. In this process, dileucine motifs interact with the b1 subunit of AP-1 (40), directing the sorting of proteins to the trans-Golgi network. The structural determinants and the mechanisms underlying BLT1 endocytosis are still not defined, but we have previously demonstrated that BLT1 C-tail is essential for BLT1 internalization, as it is for a vast number of GPCRs, and that this phenomenon is uniquely 
L292-L293 are not involved in BLT1 regulation
Surprisingly, the proximal dileucine motif (L292-L293) substitution caused only a slight increase in the number of binding sites. In Lamp1, relative spacing of the motif Yxxf from the seventh TM was shown to be important (41) . Type II integral membrane proteins expose an acidic residue membrane-distal relative to a dileucine motif, whereas in membrane type I proteins, the acidic residue is membrane-proximal relative to the dileucine. These sequences have been proposed to exist in two forms: membrane-distal accessible dileucines mediate direct transport from the trans-Golgi network to endosomes, whereas membrane-proximal non-accessible dileucines are involved in the regulation of trafficking from the plasma membrane to endosomes. The latter motifs have been suggested to become accessible through phosphorylation of an adjacent Ser/Thr residue (19), although such phosphoserine-dependent AP1 binding has also been shown for the membranedistal dileucine motif in the mannose-6-phosphate receptor (42) . The proximal dileucine motif in BLT1 is located immediately after three glycines, which seem to delimit the end of the seventh TM.
Therefore this motif might be positioned too close to the seventh TM to be recognized. Some dileucine-based endocytic signals are recognized constitutively or upon post-translational modification such as phosphorylation of a nearby amino-terminally positioned phosphoacceptor residue (21, [43] [44] [45] , which may open the structure exposing the signal sequence or simply stabilizing the interaction with the endocytic apparatus.
BLT1 activation
The distal dileucine motif L304-L305 of BLT1 C-tail thus appears to regulate the population of receptors in the active state and, hence, the number of binding sites for LTB 4 . More binding sites are detected when the C-tail is removed or the distal dileucine motif is abrogated, suggesting that WT BLT1 binding sites may in fact represent only a fraction of the total LTB 4 binding capacity of the cell. In order to obtain structural information on the distal dileucine motif and possibly a functional explanation for the characteristics displayed by mutant BLT1, we used molecular modeling.
Modelization of BLT1 structure on the bovine rhopdosin model.
The homology model of the BLT1 was based on the crystal structure of bovine rhodopsin and was obtained as described elsewhere (36). In our model, it can be seen that the two dileucine motifs are located within helix VIII and that the distal motif is involved in an hydrophobic core containing other hydrophobic residues in helix VIII (of which the strictly conserved Phe and that we can neglect the effect of the mutation on the active state, it can be hypothesized that the mutant BLT1 will be more easily activated or will have a smaller free energy (∆G) of activation than the WT receptor (Fig. 7C) .
One way to experimentally verify this hypothesis, i.e. that the ∆G of activation is smaller or that the population of receptor in the active state is greater, is to assess the activity of the receptor in absence of agonist or to detect increased constitutive activity for the mutant BLT1. Indeed, we found the existence of such increased constitutive activity for the 2L(L304-5)/A mutant receptor, therefore suggesting that this mutant has a decreased ∆G of activation and that the receptor is destabilized in its inactivated form. Of course, the active state of the receptor could also be stabilized by the Curiously, removal or switching of the BLT1 C-tail with PAFR or CysLT1 did not modify the coupling selectivity of BLT1 (33; and data not shown). This latter observation suggests that helix VIII is not interacting directly with the G-protein. It is plausible that helix VIII may hide high affinity sites for the G-protein and that, upon activation of the receptor, the movement of this amphipathic helix reveals those high affinity sites, mainly located in the cytoplasmic loops.
Moreover, crosslinking data from bovine rhodopsin suggest that the conformational movement of helix VIII upon activation is quite large (51,52). an elegant demonstration that the helix VIII and the distal dileucine motif of BLT1 may be involved in the conformational changes required for receptor desensitization following G-protein activation (53). As extensively shown, GRKs are involved in both GPCR desensitization and internalization, even if these processes can be fully distinguished from one another. The presence of T308 near helix VIII is interesting since it is targeted by GRK6 in BLT1 desensitization following long-term exposure to LTB 4 (33). We cannot exclude that phosphorylation of T308 by GRKs might also be a relevant event in BLT1 internalization, opening the C-tail structure and allowing accessibily of the L304-L305 motif. On the other hand, neither substitution of T308 for alanine nor deletion of the BLT1 C-tail from residue 306 changed the receptor pharmacological characteristics compared to WT BLT1, in terms of ligand binding properties and basal receptor activity (33, 53). The latter observations may be associated with the fact that residue T308 is located outside of helix VIII.
Conclusion
With the present investigation, we provide evidence that a specific dileucine motif in a GPCR helix VIII is actively involved in modulation of ligand binding through regulation of the receptor activation process. In addition, we demonstrate for the first time that agonist-induced internalization of a GPCR depends on the helix VIII dileucine-based motif. Since BLT1 internalizes through a dynamin-and clathrin-dependent, but arrestin-independent pathway, the search for adaptor proteins that promote BLT1 sequestration remains open. PAFR and CysLT1 C-tail sequences in the chimeric receptors are underligned. is also shown in blue helix 8 which is perpendicular to helix VII. Spaced filling representation of residues L292-L293 (white), L304-L305 (yellow) and those forming intra-helical (blue) and interhelical (green) contacts with L304-L305. C. Simplified thermodynamic energy state diagram for activation of GPCR. At equilibrium, the population of receptors in each state is determined by its relative energy and the population of receptors in the active form is determined by the ability of the receptors to overcome the energy difference between the R and R* states. Table I Binding characteristics of WT and modified BLT1.
WT and mutant BLT1 were transiently expressed in COS-7 cells and assessed for ligand binding as Table III Internalization levels of WT and mutant BLT1.
Myc-tagged WT and mutant BLT1 were transiently expressed in HEK 293 cells. 48 h posttransfection, cells were exposed to 300 nM LTB 4 or its vehicle (ethanol) and expression was assessed by cytofluorometric analysis. Receptors were labeled with anti-Myc antibody followed by FITC 
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